2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
Reports Fourth Quarter and Year End 2024 Financial Results
To Acquire, Further Diversifying Oncology Portfolio
Amended material disclosure
Other Events
Material disclosure
Investor Presentation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Amended Annual Report
FY 2024
Q3
Q2
Q1
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notification Filed by a National Security Exchange
Post-Effective Amendment to Registration Statement
S-8 POS